This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Kind Consumer Limited. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: The Innovative Mind of Chris Moyses
Introduction
Chris Moyses, an inventive spirit based in Oxford, United Kingdom, has made significant contributions to the field of pharmaceutical compositions. With a focus on developing novel inhalable nicotine products, he stands at the forefront of innovation in this area.
Latest Patents
Moyses holds a noteworthy patent titled "Nicotine Composition." This invention outlines an inhalable composition that includes nicotine or a suitable derivative, combined with a propellant, monohydric alcohol, and glycol or glycol ether. The unique aspect of this patent is defined by the specified ratio of monohydric alcohol to glycol or glycol ether by weight, ranging from 6:1 to 1:1, showcasing his deep understanding of the chemistry involved in effective nicotine delivery systems.
Career Highlights
Currently, Chris Moyses is associated with Kind Consumer Limited, a company committed to developing innovative consumer products in the health sector. His work exemplifies the integration of scientific research with practical applications, aiming to facilitate safer nicotine consumption methods.
Collaborations
Moyses collaborates with talented colleagues such as Alex Hearn and Stuart Bhimsen Lowe. This dynamic team fosters a creative environment where innovative ideas can flourish, ultimately contributing to their shared goals of advancing health-related products.
Conclusion
Chris Moyses is a key figure in the development of modern nicotine compositions, and his work continues to pave the way for safer inhalation methods. With his patent and collaborative efforts at Kind Consumer Limited, Moyses remains an influential innovator in the pharmaceutical landscape.